Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genomics insights of SARS-CoV-2 (COVID-19) into target-based drug discovery
P. Chellapandi, S. Saranya
Medicinal Chemistry Research (2020) Vol. 29, Iss. 10, pp. 1777-1791
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Identification of pivotal genes and pathways in Chorea-acanthocytosis using comprehensive bioinformatic analysis
Ravinder Sharma, Kiran Yadav, Leeza Monga, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0309594-e0309594
Open Access
Mutations in SARS-CoV
Firasat Hussain, Javed Muhammad, Amjad Khan, et al.
BENTHAM SCIENCE PUBLISHERS eBooks (2024), pp. 60-86
Closed Access
The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing
Zeinab Yousefi Najafabadi, Songwe Fanuel, Reza Falak, et al.
Molecular Biotechnology (2022) Vol. 65, Iss. 2, pp. 146-161
Open Access | Times Cited: 3
Target SARS-CoV-2: theoretical exploration on clinical suitability of certain drugs
S. M. Abdul Nayeem, Ershad Mohammed Sohail, N. V. Srihari, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 19, pp. 8905-8912
Open Access | Times Cited: 4
Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules
Ika Oktavianawati, Mardi Santoso, Mohd Fadzelly Abu Bakar, et al.
Applied Biological Chemistry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 1
Homology Modeling and Binding Site Analysis of SARS-CoV-2 (COVID-19) Main Protease 3D Structure
Marion O. Adebiyi, Ibidun Christiana Obagbuwa
IGI Global eBooks (2023), pp. 933-947
Closed Access | Times Cited: 1
A rapid and cost-effective multiplex ARMS-PCR method for the simultaneous genotyping of the circulating SARS-CoV-2 phylogenetic clades
Md. Tanvir Islam, A. S. M. Rubayet Ul Alam, Najmuj Sakib, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Viral Transmission via Enhanced Furin-mediated Spike Cleavage
Ya‐Wen Cheng, Tai‐Ling Chao, Chiao‐Ling Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2
A Perspective on Immune Cell Metabolic Models for Hostbased Therapeutic Discovery against COVID-19
P. Chellapandi
(2021) Vol. 6, Iss. 1
Open Access | Times Cited: 2
A Comprehensive Review and Perspective of Herbal Medicines in the Treatment of COVID-19
Afrasim Moin, S. Meenakshi, Syed Mohd Danish Rizvi, et al.
Journal of Pharmaceutical Research International (2021), pp. 70-95
Open Access | Times Cited: 2
History, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)
Vishwas Tripathi, Amaresh Mishra, Nisha Nair, et al.
Coronaviruses (2021) Vol. 3, Iss. 1
Closed Access | Times Cited: 2
Computational Prediction of Cymbopogon Citratus Compounds as Promising Inhibitors of Main Protease of SARS-CoV-2
Tuba Ahmad, Rashid Saif, Muhammad Hassan Raza, et al.
Futuristic Biotechnology (2022), pp. 20-25
Open Access | Times Cited: 1
A rapid and cost-effective multiplex ARMS-PCR method for the simultaneous genotyping of the circulating SARS-CoV-2 phylogenetic clades
Md. Tanvir Islam, A. S. M. Rubayet Ul Alam, Najmuj Sakib, et al.
Authorea (Authorea) (2020)
Open Access | Times Cited: 1
COVID-19 (Symptomatic Non-Respiratory) with Type 2 Diabetes Mellitus
Nursin Abdul Kadir, Ida Parwati
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY (2023) Vol. 29, Iss. 1, pp. 101-106
Open Access
De Novo Drug Design of Potential Inhibitors of SARS-CoV-2 Papain-like Protease
Edgar Clyde R. Lopez
(2023), pp. 37-37
Open Access
Homology Modeling and Binding Site Analysis of SARS-CoV-2 (COVID-19) Main Protease 3D Structure
Marion O. Adebiyi, Ibidun Christiana Obagbuwa
Advances in healthcare information systems and administration book series (2022), pp. 79-96
Closed Access
Computer-Aided Drug Designing of Ocimum basilicum Compounds as Therapeutic Agents against RdRp of SARS-CoV2
Mehwish Shafiq, Rashid Saif, Laraib Ali, et al.
Futuristic Biotechnology (2022), pp. 19-23
Open Access
Blocking SARS-CoV-2 Spike Protein binding to ACE2 receptor through Narcotinic Compounds Combined with Adjuvants: an in silico Insight
Saeedeh Mohammadi, Ayoub Esmailpour, Nader Sakhaee, et al.
Research Square (Research Square) (2021)
Closed Access
Bioinformatic Application in COVID-19
Gurjot Kaur, Soham Mukherjee, Shreya Jaiswal
Springer eBooks (2021), pp. 87-104
Closed Access
Covid-19 Drug Targets and Therapeutics: A Review
Pranay Choudhary, Velmurugan Janaki Devi
International Journal of Zoological Investigations (2021) Vol. 7, Iss. 2, pp. 987-996
Open Access
Previous Page - Page 2

Scroll to top